Showing results (11-20 of 53) with videos related to
Sort By:
Pageof 6
Current Treatment Options in Oncology|May 3, 2014
Update on vaccines for high-risk melanomaSarah A Weiss, Sunandana Chandra, Anna C PavlickCancer|August 27, 2015
Revisiting determinants of prognosis in cutaneous melanomaSarah A Weiss, Douglas Hanniford, Eva Hernando, et al.Journal for Immunotherapy of Cancer|October 19, 2019
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanomaCatherine A Gao, Urs M Weber, Aldo J Peixoto, et al.Case Reports in Radiology|November 10, 2025
Metastatic Merkel Cell Carcinoma Incidentally Detected on PSMA PET/CT in a Patient With Metastatic Prostate CancerWilliam Y Raynor, Manas Ranpariya, Jeffrey S Kempf, et al.Frontiers in Transplantation|July 12, 2024
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignanciesStephanie Ji, Hao Liu, Laura Pachella, et al.Journal of Medical Case Reports|February 24, 2022
Mononeuritis multiplex as a rare and severe neurological complication of immune checkpoint inhibitors: a case reportSafa Abdelhakim, Jonah D Klapholz, Bhaskar Roy, et al.Nature Immunology|June 18, 2021
Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunityJenna L Collier, Sarah A Weiss, Kristen E Pauken, et al.Journal of Neuro-Oncology|September 25, 2020
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastasesSarah A Weiss, Christopher Zito, Thuy Tran, et al.Journal of Translational Medicine|October 21, 2016
Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohortsSarah A Weiss, Joseph Han, Farbod Darvishian, et al.Oncology|July 27, 2017
Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the LiteratureKierstin Utter, Chloe Goldman, Sarah A Weiss, et al.Pageof 6